State Street SPDR S&P Pharmaceuticals ETF ( XPH) - Dividend Growth Rate (DGR)
XPH Dividend Growth Rate for past 3 years (DGR3)
Dividend history for stock XPH (State Street SPDR S&P Pharmaceuticals ETF) including dividend growth rate predictions based on history.
| Year | Dividend | Estimated Yield on Cost |
|---|---|---|
| 2036 | 0.932USD | 1.55% |
| 2035 | 0.875USD | 1.45% |
| 2034 | 0.821USD | 1.36% |
| 2033 | 0.771USD | 1.28% |
| 2032 | 0.724USD | 1.20% |
| 2031 | 0.679USD | 1.13% |
| 2030 | 0.638USD | 1.06% |
| 2029 | 0.599USD | 0.99% |
| 2028 | 0.562USD | 0.93% |
| 2027 | 0.527USD | 0.88% |
| 2026 | 0.495USD | 0.82% |
XPH Dividend Growth Rate for past 5 years (DGR5)
| Year | Dividend | Estimated Yield on Cost |
|---|---|---|
| 2036 | 5.506USD | 9.14% |
| 2035 | 4.398USD | 7.30% |
| 2034 | 3.513USD | 5.83% |
| 2033 | 2.806USD | 4.66% |
| 2032 | 2.241USD | 3.72% |
| 2031 | 1.790USD | 2.97% |
| 2030 | 1.430USD | 2.37% |
| 2029 | 1.142USD | 1.90% |
| 2028 | 0.912USD | 1.51% |
| 2027 | 0.729USD | 1.21% |
| 2026 | 0.582USD | 0.97% |
XPH Dividend Growth Rate for past 10 years (DGR10)
| Year | Dividend | Estimated Yield on Cost |
|---|---|---|
| 2036 | 0.979USD | 1.63% |
| 2035 | 0.915USD | 1.52% |
| 2034 | 0.855USD | 1.42% |
| 2033 | 0.799USD | 1.33% |
| 2032 | 0.747USD | 1.24% |
| 2031 | 0.698USD | 1.16% |
| 2030 | 0.652USD | 1.08% |
| 2029 | 0.609USD | 1.01% |
| 2028 | 0.570USD | 0.95% |
| 2027 | 0.532USD | 0.88% |
| 2026 | 0.497USD | 0.83% |
XPH
Price: $60.22
Dividend Yield: 0.67%
Forward Dividend Yield: 0.40%
Payout Ratio: 28.04%
Dividend Per Share: 0.24 USD
Earnings Per Share: 3.02 USD
P/E Ratio: 18.07
Exchange: PCX
Sector: Financial Services
Industry: Asset Management
Volume: 26100
Market Capitalization: 224.6 million
Average Dividend Frequency: 4
Years Paying Dividends: 21
DGR3: 6.53%
DGR5: 25.20%
DGR10: 7.01%